Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$2.9 million.

  • Maravai Lifesciences Holdings' Change in Account Payables fell 2008.26% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $422000.0, marking a year-over-year increase of 22968.75%. This contributed to the annual value of $723000.0 for FY2024, which is 8631.72% down from last year.
  • Maravai Lifesciences Holdings' Change in Account Payables amounted to -$2.9 million in Q3 2025, which was down 2008.26% from $1.8 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Change in Account Payables high stood at $4.6 million for Q2 2024, and its period low was -$4.4 million during Q3 2022.
  • Moreover, its 5-year median value for Change in Account Payables was $1.7 million (2023), whereas its average is $172263.2.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Change in Account Payables soared by 1322352.94% in 2021, and later plummeted by 146680.85% in 2024.
  • Maravai Lifesciences Holdings' Change in Account Payables (Quarter) stood at -$867000.0 in 2021, then crashed by 300.0% to -$3.5 million in 2022, then soared by 147.84% to $1.7 million in 2023, then surged by 35.86% to $2.3 million in 2024, then crashed by 228.93% to -$2.9 million in 2025.
  • Its Change in Account Payables stands at -$2.9 million for Q3 2025, versus $1.8 million for Q2 2025 and -$708000.0 for Q1 2025.